Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$9.99 - $14.91 $289 - $432
29 New
29 $0
Q2 2023

Aug 01, 2023

BUY
$7.23 - $10.52 $679 - $988
94 New
94 $0
Q3 2022

Nov 08, 2022

BUY
$7.76 - $13.72 $605 - $1,070
78 Added 90.7%
164 $1,000
Q2 2022

Aug 10, 2022

BUY
$10.22 - $13.94 $878 - $1,198
86 New
86 $1,000
Q1 2020

Apr 23, 2020

SELL
$3.53 - $12.21 $222 - $769
-63 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$11.58 - $17.37 $729 - $1,094
63 New
63 $1,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.